Page last updated: 2024-10-28

miltefosine and Respiratory Tract Infections

miltefosine has been researched along with Respiratory Tract Infections in 1 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Respiratory Tract Infections: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.

Research Excerpts

ExcerptRelevanceReference
"Miltefosine has structural similarity to the PC and sphingomyelin substrates of PlcHR, and we found that it inhibits the cleavage of these choline-containing lipids in vitro."1.37Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection. ( Allard, JL; Allen, GB; Gross, MJ; Hogan, DA; Leclair, LW; Lundblad, LK; Rajamani, S; Vasil, ML; Wargo, MJ, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wargo, MJ1
Gross, MJ1
Rajamani, S1
Allard, JL1
Lundblad, LK1
Allen, GB1
Vasil, ML1
Leclair, LW1
Hogan, DA1

Other Studies

1 other study available for miltefosine and Respiratory Tract Infections

ArticleYear
Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection.
    American journal of respiratory and critical care medicine, 2011, Aug-01, Volume: 184, Issue:3

    Topics: Animals; Antifungal Agents; Bronchoalveolar Lavage Fluid; Cystic Fibrosis; Disease Models, Animal; H

2011